abstract |
ABSTRACT The present invention relates to new stromelysin (human) - inhibitors, i.e., physiologically active substances BE-16627 represented by the general formula: [I] wherein R represents a hydrogen atom or a methyl group, or pharmaceutically acceptable salts thereof, a process for the production and use thereof, and a microorganism producing the substance BE-16627. |